Trends in mortality and the effects of the COVID-19 pandemic on mortality among adult patients with Staphylococcus aureus bacteremia, 20 US counties, 2005-2022

Résumé fourni par la source

Abstract Background Trends in Staphylococcus aureus bacteremia (SAB) mortality rates in the United States, including the impact of COVID-19, have not been well described. Methods Active, laboratory- and population-based surveillance data from 20 counties (seven states) were used to examine annual, 30-day mortality rates among U.S. adult patients with methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA and MSSA, respectively) bacteremia during 2005-2022. Medical records and state vital statistics data were linked to ascertain death. Multivariable survival analysis estimated the association between recent SARS-CoV-2 infection (a positive SARS-CoV-2 test ≤30 days before incident culture) and mortality among SAB cases, adjusting for demographics and other risk factors. Analyses were stratified by MRSA/MSSA and epidemiologic class (hospital-onset [HO], healthcare-associated community-onset [HACO], and community-associated [CA]). Results Overall, SAB mortality was 21%. Annual SAB mortality rates were generally stable pre-pandemic before increasing by 33% and 41% among HO MRSA and MSSA cases, respectively, and by 49% among CA MRSA cases, but not among HACO or MSSA CA cases, from 2019 through 2021. Among HO cases with recent SARS-CoV-2 infection, annual mortality rates were as high as 75%. Adjusted hazard ratios for recent SARS-CoV-2 infection ranged from 1.9 (95% confidence interval: 1.5-2.3) (HACO MRSA) to 3.0 (95% confidence interval: 2.4-3.7) (HO MSSA). Conclusions Recent SARS-CoV-2 infection was a significant risk factor for death among patients with SAB during 2020-2022. Strengthening infection prevention efforts in similar respiratory pandemics in the future could help prevent increases in SAB mortality rates.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.